US Stock MarketDetailed Quotes

Quoin Pharmaceuticals (QNRX)

Watchlist
  • 5.900
  • +0.160+2.79%
Close Apr 10 16:00 ET
  • 5.900
  • 0.0000.00%
Post 20:01 ET
10.64MMarket Cap-0.40P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quoin Pharmaceuticals (QNRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
70.97%16.29M
87.96%4.52M
59.02%4.02M
77.49%3.79M
60.97%3.96M
1.60%9.53M
8.45%2.41M
18.95%2.53M
-5.44%2.14M
-11.43%2.46M
Selling and administrative expenses
9.49%6.49M
5.07%1.42M
20.05%1.74M
12.45%1.74M
0.64%1.58M
-2.38%5.93M
-2.20%1.35M
5.99%1.45M
-5.22%1.55M
-6.58%1.57M
-General and administrative expense
9.49%6.49M
5.07%1.42M
20.05%1.74M
12.45%1.74M
0.64%1.58M
-2.38%5.93M
-2.20%1.35M
5.99%1.45M
-5.22%1.55M
-6.58%1.57M
Research and development costs
172.10%9.8M
194.88%3.1M
111.29%2.28M
249.03%2.05M
168.17%2.37M
8.91%3.6M
26.17%1.05M
42.29%1.08M
-6.02%587.5K
-18.91%885.3K
Operating profit
-70.97%-16.29M
-87.96%-4.52M
-59.02%-4.02M
-77.49%-3.79M
-60.97%-3.96M
-1.60%-9.53M
-8.45%-2.41M
-18.95%-2.53M
5.44%-2.14M
11.43%-2.46M
Net non-operating interest income expense
-13.68%482.08K
57.05%171.7K
-57.47%62.27K
-37.53%103.25K
5.35%144.87K
-19.60%558.49K
-31.04%109.33K
-25.47%146.39K
-11.90%165.26K
-9.56%137.51K
Non-operating interest income
-13.68%482.08K
57.05%171.7K
-57.47%62.27K
-37.53%103.25K
5.35%144.87K
-19.60%558.49K
-31.04%109.33K
-25.47%146.39K
-11.90%165.26K
-9.56%137.51K
Other net income (expense)
-46.95%3.98K
102.34%364
-70.08%9.49K
-175.79%-6K
101.94%126
379.61%7.5K
-268.14%-15.54K
1,397.36%31.73K
93.68%-2.18K
-131.86%-6.51K
Gain on sale of security
-46.95%3.98K
102.34%364
-70.08%9.49K
-175.79%-6K
101.94%126
379.61%7.5K
-268.14%-15.54K
1,397.36%31.73K
93.68%-2.18K
-131.86%-6.51K
Income before tax
-76.34%-15.8M
-88.14%-4.35M
-68.02%-3.95M
-87.23%-3.7M
-63.80%-3.81M
-3.18%-8.96M
-12.75%-2.31M
-21.97%-2.35M
6.31%-1.97M
10.59%-2.33M
Income tax
Net income
-76.34%-15.8M
-88.14%-4.35M
-68.02%-3.95M
-87.23%-3.7M
-63.80%-3.81M
-3.18%-8.96M
-12.75%-2.31M
-21.97%-2.35M
6.31%-1.97M
10.59%-2.33M
Net income continuous Operations
-76.34%-15.8M
-88.14%-4.35M
-68.02%-3.95M
-87.23%-3.7M
-63.80%-3.81M
-3.18%-8.96M
-12.75%-2.31M
-21.97%-2.35M
6.31%-1.97M
10.59%-2.33M
Minority interest income
Net income attributable to the parent company
-76.34%-15.8M
-88.14%-4.35M
-68.02%-3.95M
-87.23%-3.7M
-63.80%-3.81M
-3.18%-8.96M
-12.75%-2.31M
-21.97%-2.35M
6.31%-1.97M
10.59%-2.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-76.34%-15.8M
-88.14%-4.35M
-68.02%-3.95M
-87.23%-3.7M
-63.80%-3.81M
-3.18%-8.96M
-12.75%-2.31M
-21.97%-2.35M
6.31%-1.97M
10.59%-2.33M
Basic earnings per share
78.24%-518
85.80%-1.74
58.81%-6.71
54.09%-6.28
83.22%-6.5
-605.60%-2.38K
83.14%-12.25
76.13%-16.29
81.65%-13.68
72.94%-38.73
Diluted earnings per share
78.24%-518
85.80%-1.74
58.81%-6.71
54.09%-6.28
83.22%-6.5
-605.60%-2.38K
83.17%-12.25
76.13%-16.29
81.65%-13.68
72.94%-38.73
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 70.97%16.29M87.96%4.52M59.02%4.02M77.49%3.79M60.97%3.96M1.60%9.53M8.45%2.41M18.95%2.53M-5.44%2.14M-11.43%2.46M
Selling and administrative expenses 9.49%6.49M5.07%1.42M20.05%1.74M12.45%1.74M0.64%1.58M-2.38%5.93M-2.20%1.35M5.99%1.45M-5.22%1.55M-6.58%1.57M
-General and administrative expense 9.49%6.49M5.07%1.42M20.05%1.74M12.45%1.74M0.64%1.58M-2.38%5.93M-2.20%1.35M5.99%1.45M-5.22%1.55M-6.58%1.57M
Research and development costs 172.10%9.8M194.88%3.1M111.29%2.28M249.03%2.05M168.17%2.37M8.91%3.6M26.17%1.05M42.29%1.08M-6.02%587.5K-18.91%885.3K
Operating profit -70.97%-16.29M-87.96%-4.52M-59.02%-4.02M-77.49%-3.79M-60.97%-3.96M-1.60%-9.53M-8.45%-2.41M-18.95%-2.53M5.44%-2.14M11.43%-2.46M
Net non-operating interest income expense -13.68%482.08K57.05%171.7K-57.47%62.27K-37.53%103.25K5.35%144.87K-19.60%558.49K-31.04%109.33K-25.47%146.39K-11.90%165.26K-9.56%137.51K
Non-operating interest income -13.68%482.08K57.05%171.7K-57.47%62.27K-37.53%103.25K5.35%144.87K-19.60%558.49K-31.04%109.33K-25.47%146.39K-11.90%165.26K-9.56%137.51K
Other net income (expense) -46.95%3.98K102.34%364-70.08%9.49K-175.79%-6K101.94%126379.61%7.5K-268.14%-15.54K1,397.36%31.73K93.68%-2.18K-131.86%-6.51K
Gain on sale of security -46.95%3.98K102.34%364-70.08%9.49K-175.79%-6K101.94%126379.61%7.5K-268.14%-15.54K1,397.36%31.73K93.68%-2.18K-131.86%-6.51K
Income before tax -76.34%-15.8M-88.14%-4.35M-68.02%-3.95M-87.23%-3.7M-63.80%-3.81M-3.18%-8.96M-12.75%-2.31M-21.97%-2.35M6.31%-1.97M10.59%-2.33M
Income tax
Net income -76.34%-15.8M-88.14%-4.35M-68.02%-3.95M-87.23%-3.7M-63.80%-3.81M-3.18%-8.96M-12.75%-2.31M-21.97%-2.35M6.31%-1.97M10.59%-2.33M
Net income continuous Operations -76.34%-15.8M-88.14%-4.35M-68.02%-3.95M-87.23%-3.7M-63.80%-3.81M-3.18%-8.96M-12.75%-2.31M-21.97%-2.35M6.31%-1.97M10.59%-2.33M
Minority interest income
Net income attributable to the parent company -76.34%-15.8M-88.14%-4.35M-68.02%-3.95M-87.23%-3.7M-63.80%-3.81M-3.18%-8.96M-12.75%-2.31M-21.97%-2.35M6.31%-1.97M10.59%-2.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -76.34%-15.8M-88.14%-4.35M-68.02%-3.95M-87.23%-3.7M-63.80%-3.81M-3.18%-8.96M-12.75%-2.31M-21.97%-2.35M6.31%-1.97M10.59%-2.33M
Basic earnings per share 78.24%-51885.80%-1.7458.81%-6.7154.09%-6.2883.22%-6.5-605.60%-2.38K83.14%-12.2576.13%-16.2981.65%-13.6872.94%-38.73
Diluted earnings per share 78.24%-51885.80%-1.7458.81%-6.7154.09%-6.2883.22%-6.5-605.60%-2.38K83.17%-12.2576.13%-16.2981.65%-13.6872.94%-38.73
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th local time, Pakistani officials confirmed that delegations from the United States and Iran will hold negotiations Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -